Table 2.
Comparison of ABR parameters in patients with vitiligo and control subjects
|
Patient group (n=21)
|
Control group (n=20)
|
||
|---|---|---|---|
| Ear/Variable | Mean ±SD(ms) | Mean ±SD(ms) | P |
| R/ I Latency | 1.50±0.12 | 1.47±0.10 | 0.432 |
| L/ I Latency | 1.50±0.13 | 1.43±0.14 | 0.191 |
| R/ III Latency | 3.63±0.25 | 3.45±0.10 | 0.022* |
| L/ III Latency | 3.62±0.17 | 3.44±0.11 | 0.001* |
| R/ V Latency | 5.46±0.26 | 5.42 ±0.16 | 0.629 |
| L/ V Latency | 5.44±0.21 | 5.39±0.17 | 0.410 |
| R/IPL I-III Latency | 2.18±0.27 | 1.99±0.13 | 0.009* |
| L/IPL I-III Latency | 2.11±0.11 | 2.01±0.15 | 0.033* |
| R/IPL III-V Latency | 1.83±0.14 | 1.96±0.12 | 0.005* |
| L/IPL III-V Latency | 1.82±0.13 | 1.94±0.19 | 0.007* |
| R/IPL I-V Latency | 3.96±0.22 | 3.81±0.63 | 0.990 |
| L/IPL I-V Latency | 3.93±0.18 | 3.95±0.19 | 0.506 |